Backlog Justice Act of 2026
Summary
The Backlog Justice Act of 2026 (H.R. 10426), introduced in the House on September 16, 2026, is in the early legislative stage, referred to the House Judiciary Committee. It authorizes $5 million annually for FY2027-2031 to improve sexual assault evidence kit testing, including a national database and analyst training. No market data is provided, and the bill's direct market impact is minimal, with no specific public companies named.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.H.R. 10426 is an early-stage bill referred to the House Judiciary Committee, with no market-moving potential in its current form.
- 2.The bill authorizes $25 million over five years (FY2027-2031) for SAEK testing improvements, but this is an authorization, not an appropriation.
- 3.No public companies are directly named or obligated by the bill; the primary impact is on state and local forensic labs.
- 4.The bill's sector impact is limited to 'Healthcare' and 'Government', but with no ticker-level effects.
- 5.Retail investors should not expect any market movement from this bill; it is a procedural, low-impact piece of legislation.
Market Implications
The Backlog Justice Act of 2026 has no direct market implications. It does not name any public companies, create a new market, or alter the competitive landscape for any sector. The $25 million authorization over five years is trivial relative to the size of any public company. The bill's focus on forensic testing and data reporting affects state and local government entities, not publicly traded firms. Even if the bill were to pass, the funding is not guaranteed (requires appropriations), and the mechanisms (database, training) do not create a clear revenue stream for any private company. Therefore, no tickers are affected, and the market impact is negligible.
Full Analysis
The Backlog Justice Act of 2026 (H.R. 10426) was introduced by Rep. Emanuel Cleaver (D-MO) on September 16, 2026, and referred to the House Committee on the Judiciary. It is in the early legislative stage, with no committee hearings or markup yet. The bill authorizes $5 million per fiscal year from 2027 through 2031 (total $25 million) for two main purposes: establishing a publicly accessible national database of aggregated, anonymized data on sexual assault evidence collection kits (SAECKs) and their testing times, and providing training for analysts to test these kits, including at FBI or state/local laboratories. The bill does not appropriate funds; it only sets authorization ceilings, requiring separate appropriations legislation to actually disburse money. The bill's impact on the private sector is indirect and diffuse. It primarily affects state and local government forensic service providers and laboratories, which would need to comply with data reporting and potentially hire or train analysts. No specific public companies are mentioned in the bill text, and the causal chain to any publicly traded entity is weak. The bill does not target any specific industry or technology class beyond forensic testing, which is largely a government and academic function. Given the early stage, the small funding amount, and the lack of direct private-sector obligations, the market impact is minimal. The bill is unlikely to move any sector or ticker in the near term. The legislative path forward includes committee consideration, potential amendments, floor votes in both chambers, and presidential action, but no timeline is set. For retail investors, this bill presents no actionable market signal.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
LOUSIANA DEPARTMENT OF HEALTH: $16.7B Department of Health and Human Services Grant
GEORGIA DEPARTMENT OF COMMUNITY HEALTH: $14.2B Department of Health and Human Services Grant
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $13.6B Department of Health and Human Services Grant
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $11.3B Department of Health and Human Services Grant
STATE OF RHODE ISLAND DEPARTMENT OF ADMINISTRATION: $2.8B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CALIFORNIA: $1.5B Department of Health and Human Services Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.7B Department of Homeland Security Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →